Nanomedicine and nano delivery systems are a young but rapidly growing discipline in which small materials are employed as diagnostic tools or to deliver therapeutic drugs to specific sites in a controlled manner. Nanotechnology has a wide range of applications in the treatment of chronic human diseases, including the delivery of precise medicines to specific locations and targets. In recent years, nanomedicine (chemotherapeutic agents, biological agents, immunotherapeutic agents, and so on) has seen a number of notable uses in the treatment of various diseases. Coronary artery disease (CAD) is currently one of the main causes of death in the Western world, and nanotechnology has the potential to provide a new supplementary strategy to treating it. It caused more than 17.3 million deaths each year in 2017, with that number anticipated to climb to more than 23.6 million by 2030. It can carry a number of payloads, like as medications and genes, to the arteries, which can help with a variety of issues. Nanotechnology offers diverse nanomaterial coatings, as well as controlled-release nanocarriers, to improve the efficacy of existing stents and avoid in-stent restenosis.
It has the potential to increase medication efficiency,
improve local and systematic distribution to atherosclerotic plaques, and
decrease the inflammatory or angiogenic response after intravascular
intervention. Imaging and diagnostic substances could be delivered to exact
targets using nanocarriers. Researchers, engineers, biomedical engineers,
nanotechnologists, and doctors must work together closely to achieve this. As
technology and evidence improve, traditional therapy modalities may be called
into question, and nanotherapeutics may eventually take their place.
Author(S) Details
Deeksha Dhingra
Department of Chemistry, Ct
University, Ludhiana, Punjab, India.
View Book:- https://stm.bookpi.org/NVST-V10/article/view/4895
No comments:
Post a Comment